|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||||||||||||
|
||||||||||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s9FE6EBF0-5EE3-11EF-B27B-29F984CE164B&I=39IZM&T=&OP=Display&O=html&O1=15695849&O2=954925430322&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DCarboplatin%2520and%2520pegylated%2520liposomal%2520doxorubicin%2520for%2520advanced%2520ovarian%2520cancer%253A%2520preliminary%2520activity%2520results%2520of%2520the%2520MITO-2%2520phase%2520III%2520trial%26rft.au%3DBreda%252C%2520E%26rft.au%3DPignata%252C%2520S%26rft.au%3DSavarese%252C%2520A%26rft.au%3DScambia%252C%2520G%26rft.date%3D2009-01-01%26rft.eissn%3D1423-0232%26rft.externalDocID%3D19039248%26rft.genre%3Darticle%26rft.issue%3D1%26rft.jtitle%3DOncology%26rft.spage%3D49%26rft.volume%3D76%26rft_id%3Dinfo%253Adoi%252F10.1159%252F000178760%26rft_id%3Dinfo%253Apmid%252F19039248%26rft_id%3Dinfo%253Apmid%252F19039248%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-PROQUEST_CENTRAL-getFullTxt-object,2-DOI-getDOI-object,3-COBIB_SI_LCL-getHolding-object,4-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,5-EBSCOHOST_ACADEMIC_SEARCH_COMPLETE-getTOC-object,6-EBSCOHOST_ACADEMIC_SEARCH_COMPLETE_UL_2024_03_LCL-getTOC-object,7-EBSCOHOST_ACADEMIC_SEARCH_COMPLETE_UM_2024_04_LCL-getTOC-object,8-EBSCOHOST_ACADEMIC_SEARCH_ELITE-getTOC-object,9-EBSCOHOST_ACADEMIC_SEARCH_PREMIER-getTOC-object,10-ISI_WEB_OF_SCIENCE-getAuthor-object,11-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,12-REFWORKS_EXPORT_TOOL-getReference-object,13-NCBI_PUBMED_FREE-getCitedRecord-object,14-SHERPA_RoMEO_LCL-getWebService-object,15-GOOGLE_SCHOLAR_FREE-getWebSearch-object,16-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.706109&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15695849-s9FE6EBF0-5EE3-11EF-B27B-29F984CE164B" timestamp="2024-08-20T13:02:01Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954925430322</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Carboplatin and Pegylated Liposomal Doxorubicin for Advanced Ovarian Cancer: Preliminary Activity Results of the MITO-2 Phase III Trial</jnl:atitle>
<jnl:jtitle>Oncology</jnl:jtitle>
<jnl:date>2009-12-01</jnl:date>
<jnl:spage>49</jnl:spage>
<jnl:epage>54</jnl:epage>
<jnl:coden>ONCOBS</jnl:coden>
<jnl:issn>0030-2414</jnl:issn>
<jnl:volume>76</jnl:volume>
<jnl:issue>1</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1423-0232</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>ONCOBS</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:751a06ac416b4792b1bcf88e96ba571dd4c1e8e6</ctx:identifier>
<ctx:identifier>urn:UUID:s9FE6EBF0-5EE3-11EF-B27B-29F984CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)